Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transcriptomics in predictive toxicology.

Thorsten Storck1, Marie-Charlotte von Brevern, Christian K Behrens

  • 1Axaron Bioscience AG, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany. storck@axaron.com

Current Opinion in Drug Discovery & Development
|February 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential Expression of Micro-RNA in Maternal Blood of Pregnancies Affected with Late-Onset Fetal Growth Restriction.

Biomedicine hub·2025
Same author

Use and limitations of clinical data in the identification and classification of low molecular weight chemicals (LMWCs) as respiratory sensitizers: recommendations for improvement.

Critical reviews in toxicology·2025
Same author

NaviCenta - The disease map for placental research.

Placenta·2023
Same author

Ten Topics to Get Started in Medical Informatics Research.

Journal of medical Internet research·2023
Same author

A proteomic profile of the healthy human placenta.

Clinical proteomics·2023
Same author

Single extracellular vesicle analysis in human amniotic fluid shows evidence of phenotype alterations in preeclampsia.

Journal of extracellular vesicles·2022

Genomics advances drug development by predicting compound toxicity using toxicogenomics. This method analyzes gene transcription changes to reveal molecular mechanisms and improve predictive toxicology.

Area of Science:

  • Genomics and Drug Development
  • Toxicology and Molecular Biology

Background:

  • Genomics has previously revolutionized target discovery and assay development in drug discovery.
  • Genomics is now being applied to predict potential toxicological issues associated with chemical compounds.
  • Toxicogenomics, the analysis of toxicology at the transcriptome level, offers a powerful new approach.

Purpose of the Study:

  • To explore the application of toxicogenomics in predicting compound toxicity during drug development.
  • To leverage transcriptome-level analysis for a deeper understanding of compound-induced toxicological effects.
  • To develop methods for analyzing novel toxicogenomic data for mechanistic and predictive toxicology.

Main Methods:

  • Toxicogenomics involves monitoring the effect of compounds on transcription levels of numerous genes simultaneously.

Related Experiment Videos

  • Analysis focuses on the transcriptome level within a target organ or cell.
  • Compilation of transcription profiles for known toxicants is used to interpret data.

    • Main Results:

    • Toxicogenomics generates vast amounts of data on how compounds act at the molecular level.
    • This data provides insights beyond simple identification of toxic outcomes.
    • Initial analysis of transcription profiles for known toxicants is underway.

    Conclusions:

    • Toxicogenomics holds significant potential to enhance drug development by predicting toxicity.
    • The approach offers a molecular-level understanding of compound actions.
    • Further development in analyzing toxicogenomic data will advance mechanistic and predictive toxicology.